Improving Adherence to Prescribing Guidelines for Cholesterol Lowering in Hospitalized Diabetic Patients
NCT ID: NCT01113099
Last Updated: 2010-04-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
247 participants
INTERVENTIONAL
2006-06-30
2007-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Academic detailing of physicians
Academic detailing
Education of physicians by pharmacists regarding indications for statins in diabetic patients
Usual care
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Academic detailing
Education of physicians by pharmacists regarding indications for statins in diabetic patients
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* LDL \>= 100
Exclusion Criteria
* Pregnancy
* Intolerance or contraindication to statin
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Washington University School of Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Washington University School of Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thomas C Bailey, MD
Role: PRINCIPAL_INVESTIGATOR
Washington University School of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Barnes Jewish Hospital
St Louis, Missouri, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
McKinnon PS, Seaton T, Noirot LA, Reichley RM, Heard KM, Shannon WD, Goldberg AC, Dunagan WC, Bailey TC. Improving adherence to dyslipidemia medication guidelines in hospitalized diabetic patients using a technology-assisted pharmacist intervention. AMIA Annu Symp Proc. 2008 Nov 6:868.
Reichley R, McKinnon PS, Seaton T, Noirot L, Dunagan WC, Bailey TC. Adherence to dyslipidemia treatment guidelines in diabetic patients. AMIA Annu Symp Proc. 2006;2006:1071.
Reichley R, Rachmiel E, Seaton T, Noirot L, Longyhore D, Dunagan WC, Bailey TC. Intervention to improve dyslipidemia screening in hospitalized diabetics. AMIA Annu Symp Proc. 2005;2005:1093.
McKinnon PS, Reichley RM, Noirot LA, Dunagan WC, Bailey TC. Prospective validation of an algorithm to identify hospitalized diabetic patients using administrative data. AMIA Annu Symp Proc. 2006;2006:1029.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
02-1072
Identifier Type: -
Identifier Source: org_study_id